Adipokines and Adipocyte Targets in the Future Management of Obesity and the Metabolic Syndrome

Publisher: Bentham Science Publishers

E-ISSN: 1875-5607|7|1|39-45

ISSN: 1389-5575

Source: Mini Reviews in Medicinal Chemistry, Vol.7, Iss.1, 2007-01, pp. : 39-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

The role of adipocytes has been recently better understood. Several adipocytokines have been identified, including leptin, a main regulator of appetite and energy expenditure, adiponectin and others, as novel insulinsensitizers/ insulin-mimetics, and some others inducing insulin resistance. Adipocytokines thus represent interesting novel drug targets in the future management of obesity.